FeNO testing in severe asthma: A clinical argument or an access constraint?

Pedro Carreiro-Martins; Frederico S. Regateiro; Jorge Ferreira; José Luís Plácido; Rita Gerardo; Cláudia Loureiro

doi:10.1016/j.pulmoe.2021.05.002

FeNO testing in severe asthma: A clinical argument or an access constraint?

Pedro Carreiro-Martins, Frederico S. Regateiro, Jorge Ferreira, José Luís Plácido, Rita Gerardo, Cláudia Loureiro

Research output: Contribution to journal › Comment/debate › peer-review

3 Citations (Scopus)

40 Downloads (Pure)

Original language	English
Pages (from-to)	383-385
Journal	Pulmonology
Volume	27
Issue number	5
Early online date	2021
DOIs	https://doi.org/10.1016/j.pulmoe.2021.05.002
Publication status	Published - Sept 2021

Keywords

Endotypes
FeNO testing
SEVERE ASTHMA

Access to Document

10.1016/j.pulmoe.2021.05.002

1-s2.0-S2531043721000957-mainProof, 213 KBLicence: CC BY-NC-ND

Cite this

@article{25e50ed04b7c449caa1c6bb04cb350b9,

title = "FeNO testing in severe asthma: A clinical argument or an access constraint?",

keywords = "Endotypes, FeNO testing, SEVERE ASTHMA",

author = "Pedro Carreiro-Martins and Regateiro, {Frederico S.} and Jorge Ferreira and Pl{\'a}cido, {Jos{\'e} Lu{\'i}s} and Rita Gerardo and Cl{\'a}udia Loureiro",

note = "Funding Information: In the preparation of this article, the authors received collaboration from the medical writer Duarte Oliveira (W4Research) financially supported by Sanofi. Sanofi had no role in the preparation of the manuscript or in the decision to submit the manuscript for publication. All authors declare collaborating and receiving fees from Sanofi and other pharmaceutical companies either through participation in advisory boards or consultancy, congress symposia, conducting clinical trials, investigator-initiated trials or grants. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = sep,

doi = "10.1016/j.pulmoe.2021.05.002",

language = "English",

volume = "27",

pages = "383--385",

journal = "Pulmonology",

issn = "2531-0429",

publisher = "Elsevier Espana S.L.U",

number = "5",

}

TY - JOUR

T1 - FeNO testing in severe asthma

T2 - A clinical argument or an access constraint?

AU - Carreiro-Martins, Pedro

AU - Regateiro, Frederico S.

AU - Ferreira, Jorge

AU - Plácido, José Luís

AU - Gerardo, Rita

AU - Loureiro, Cláudia

N1 - Funding Information: In the preparation of this article, the authors received collaboration from the medical writer Duarte Oliveira (W4Research) financially supported by Sanofi. Sanofi had no role in the preparation of the manuscript or in the decision to submit the manuscript for publication. All authors declare collaborating and receiving fees from Sanofi and other pharmaceutical companies either through participation in advisory boards or consultancy, congress symposia, conducting clinical trials, investigator-initiated trials or grants. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/9

Y1 - 2021/9

KW - Endotypes

KW - FeNO testing

KW - SEVERE ASTHMA

UR - http://www.scopus.com/inward/record.url?scp=85108517243&partnerID=8YFLogxK

U2 - 10.1016/j.pulmoe.2021.05.002

DO - 10.1016/j.pulmoe.2021.05.002

M3 - Comment/debate

C2 - 34134929

AN - SCOPUS:85108517243

SN - 2531-0429

VL - 27

SP - 383

EP - 385

JO - Pulmonology

JF - Pulmonology

IS - 5

ER -

FeNO testing in severe asthma: A clinical argument or an access constraint?

Keywords

Access to Document

Other files and links

Cite this